Considerations on Current and Future Trials in Hypertension
- 1 January 1996
- journal article
- Published by Taylor & Francis in Blood Pressure
- Vol. 5 (6) , 327-332
- https://doi.org/10.3109/08037059609078070
Abstract
Conclusive evidence from large-scale epidemiological studies has shown that hypertension is a major risk factor for cardiovascular disease. Large-scale intervention trials have indicated that, by reducing elevated blood pressure values with antihypertensive treatment, the risk can be decreased. Despite the large body of evidence on the protective effects of the blood pressure reduction, several questions concerning the benefit of antihypertensive treatment remain unanswered. This paper briefly reviews the information provided by clinical trials on antihypertensive treatment. It also critically examines the questions that have remained partially or totally unanswered and the trials that are currently addressing them. Focus is directed on the Insight Study which addresses the benefit of antihypertensive treatment in hypertensive subjects with additional cardiovascular risk factors.Keywords
This publication has 28 references indexed in Scilit:
- Ambulatory blood pressure monitoring use in hypertension research and clinical practice.Hypertension, 1993
- Low-dose clonidine administration in the treatment of mild or moderate essential hypertension: results from a double-blind placebo-controlled study (Clobass)Journal Of Hypertension, 1990
- Isolated systolic hypertension in the elderlyJournal Of Hypertension, 1990
- Blood Pressure, Change in Blood Pressure, and Cardiovascular Event Rates in Placebo-Treated Patients in the Medical Research Council TrialJournal of Cardiovascular Pharmacology, 1990
- Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectorisThe American Journal of Cardiology, 1989
- The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabeticsAmerican Heart Journal, 1988
- Opening remarks: The need to manage risk factors of coronary heart diseaseAmerican Heart Journal, 1988
- BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSUREThe Lancet, 1987
- Perspectives on systolic hypertension. The Framingham study.Circulation, 1980
- A general cardiovascular risk profile: The Framingham studyThe American Journal of Cardiology, 1976